share

6-Methyl-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Hydrobromide CAS NO 820245-55-4


Unit Price:

CAS No.:820245-55-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

6-Methyl-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Hydrobromide is a high-purity, pharmaceutically relevant heterocyclic building block and salt form. This compound is of significant value as a key synthetic intermediate in the research and development of novel active pharmaceutical ingredients (APIs). It is primarily sought after by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the synthesis of complex molecules for therapeutic applications.

Application

  • Pharmaceutical Intermediate: A critical building block in the synthesis of complex drug candidates, particularly those targeting the central nervous system (CNS) and other therapeutic areas.
  • Organic Synthesis Research: Used in academic and industrial research for constructing novel imidazopyridine-based heterocyclic scaffolds.
  • Medicinal Chemistry: Serves as a versatile precursor for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
  • Reference Standard: Can be supplied as a high-purity analytical standard for method development and quality control in API manufacturing.
  • Chemical Biology Probes: Utilized in the development of molecular probes for studying biological pathways and target engagement.

Basic Information

Product Name 6-Methyl-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Hydrobromide
CAS No. 820245-55-4
Molecular Formula C9H8N2O2·HBr
Molecular Weight 257.09 g/mol
Synonyms 6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid hydrobromide; 6-Methyl-2-imidazo[1,2-a]pyridinecarboxylic acid hydrobromide; Imidazo[1,2-a]pyridine-2-carboxylic acid, 6-methyl-, hydrobromide; 820245-55-4; 6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid HBr salt
EINECS Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized using advanced analytical techniques to confirm identity, purity, and consistency. Certificates of Analysis (COA) detailing specific results for assay, impurities, and other critical parameters are available upon request. We adhere to cGMP principles for the manufacture of pharmaceutical intermediates to support our global clientele.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed to prevent degradation from atmospheric moisture. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm
Related Substances (HPLC) Total impurities ≤ 2.0%; Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.